| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 391 | 1.599 | 458 | 657 | 896 | 11.266 | 20.001 | 21.077 |
| Total Income - EUR | - | - | 391 | 1.599 | 458 | 657 | 896 | 11.266 | 20.026 | 21.077 |
| Total Expenses - EUR | - | - | 141 | 956 | 923 | 692 | 301 | 3.577 | 5.485 | 17.546 |
| Gross Profit/Loss - EUR | - | - | 250 | 643 | -464 | -34 | 595 | 7.689 | 14.541 | 3.530 |
| Net Profit/Loss - EUR | - | - | 238 | 595 | -478 | -54 | 568 | 7.351 | 12.046 | 3.319 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Check the financial reports for the company - Lars Nutridiab Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 1.499 | 1.235 | 969 |
| Current Assets | - | - | 287 | 759 | 249 | 399 | 1.105 | 6.186 | 12.207 | 2.896 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 44 | 32 | 16 | 0 | 0 | 4.686 | 498 | 1.492 |
| Cash | - | - | 244 | 727 | 233 | 399 | 1.105 | 1.499 | 11.709 | 1.405 |
| Shareholders Funds | - | - | 282 | 638 | -23 | -77 | 493 | 7.400 | 12.095 | 3.368 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 5 | 121 | 272 | 476 | 612 | 285 | 1.590 | 799 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Lars Nutridiab Srl